ACTRN12619001568101
Recruiting
Phase 2
The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetes and Diabetic Microvascular Complications: Nephropathy, Retinopathy and Neuropathy
Monash University Malaysia0 sites116 target enrollmentNovember 13, 2019
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Monash University Malaysia
- Enrollment
- 116
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Subject, or legal representative, has voluntarily signed and dated an Informed Consent Form.
- •2\. Subject is 35\-75 years of age at screening date
- •3\. Subject has T2DM with stable glucose control (not more than 10% change in HbA1c levels over the last 2 months) AND HbA1c range should be within 6\-9%
- •4\. Subject has eGFR of 30\-89 AND has microalbuminuria as assessed by UACR of 20\-200mg/mmol, or
- •5\. Mild/moderate retinopathy as defined by: Mild: At least one microaneurysm Moderate: Hemorrhage/microaneurysm, cotton wool spots, venous beading, and intraretinal
- •microvascular abnormalities
- •6\. If subject has hypertension, he/she must have stable blood pressure control for the past 2 months with not more than 10% change and BP range should be \<145/90mmHg
Exclusion Criteria
- •1\. Subject is pregnant during screening, OR planning to be pregnant, OR not on contraception
- •2\. Subject has urine protein \>1\.5g/L during screening
- •3\. Subject has current urinary tract infection during screening (symptomatic or definitively on urine FEME: pyuria, nitrites and red blood cells)
- •4\. Subject has acute or severe chronic illness such as acute coronary syndrome, active tuberculosis, current history of cancer, liver or inflammatory disease etc.
- •5\. Subject with unstable eye diseases such as media opacity and glaucoma
- •6\. Subject has known non\-diabetic kidney disease, such as kidney stones etc
- •7\. Patient has severe chronic kidney disease (Stage 4/5 CKD, eGFR \<30ml/min/1\.73m2\)
- •8\. Subject is taking other water\-soluble antioxidants for the past 2 weeks or fat\-soluble antioxidants for the past 1 month
- •9\. Subject is a heavy smoker (\>20 sticks/day) that is currently smoking or has stopped smoking for \<1 month
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 2
The effectiveness of Vitamin E in the treatment of wounds found in the mouth of patients admitted to the intensive care unit of a reference hospital in the state of CearáOther and unspecified lesions of oral mucosaS01.5RBR-6mb4b77Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Completed
Not Applicable
Effects of Supplementation With Tocotrienol on Chronic Kidney Disease PatientsChronic Kidney DiseasesHemodialysisMicrobiotaOxidative StressInflammationNCT04900532Universidade Federal Fluminense61
Not yet recruiting
Not Applicable
Vitamin E in patients with Non-alcoholic steatohepatitis (NASH) related compensated cirrhosis: An open label, randomized control trialHealth Condition 1: K746- Other and unspecified cirrhosis ofliverCTRI/2022/09/045688Postgraduate Institute of Medical Education and Research
Completed
Phase 4
Effects of Vitamin E on the treatment of atopic dermatitisAtopic dermatitis.Atopic dermatitisIRCT201105016350N1Vice chancellery for research70
Recruiting
Phase 3
Evaluation of the effect of vitamin E in women with urinary tract infectioIRCT20210617051604N1Birjand University of Medical Sciences80